Ingenia Therapeutics인제니아테라퓨틱스(Reg.S)
950260 · KOSDAQ · ₩950260 · 인제니아테라퓨틱스(Reg.S)
₩23,500▼ ₩100 (0.42%)End-of-day · Oct 29, 2026 · End-of-day prices.
Filings
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획승인신청등결정) (IGT303 제1/2a상 임상시험계획 승인)Oct 27, 2026Open on DART
Predicted impact: Medium
Approval of IGT303 Phase 1/2a clinical trial plan; meaningful milestone for a ₩1.1T biotech.
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Sep 30, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Sep 29, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획승인신청) (IGT303 미국 1/2a상 임상시험 신청)Sep 28, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항 (IGT427(MK8748) 마일스톤 수령 예정)Sep 28, 2026Open on DART
- Amended: Insider shareholding report[기재정정]임원ㆍ주요주주특정증권등소유상황보고서Aug 25, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 25, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 25, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 25, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 25, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 25, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 25, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Aug 25, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 19, 2026Open on DART
- Securities Issuance Results Report증권발행실적보고서Aug 4, 2026Open on DART
- Amended: Prospectus[기재정정]투자설명서Jul 28, 2026Open on DART
- Terms set: Securities registration statement[발행조건확정]증권신고서(증권예탁증권)Jul 28, 2026Open on DART
- Prospectus투자설명서Jul 24, 2026Open on DART
- Amended: Securities registration statement[기재정정]증권신고서(증권예탁증권)Jul 21, 2026Open on DART
- Amended: Securities registration statement[기재정정]증권신고서(증권예탁증권)Jul 1, 2026Open on DART
- Securities registration statement증권신고서(증권예탁증권)Jun 10, 2026Open on DART
Titles in Korean until English translations are added.
Also known as: Ingenia Therapeutics / 인제니아테라퓨틱스(Reg.S) / 950260 / KRX:950260
Source: KRX statistical information